Global biopharmaceutical company AstraZeneca is to invest $50 million to carry out dozens of clinical trials in Abu Dhabi in a major partnership with one of the emirate's leading hospitals. The company is joining forces with Cleveland Clinic Abu Dhabi in a long-term drive to address pressing healthcare challenges, with the first studies expected to start before the end of the year.